Dr.Alfieri Salvatore – Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current position: Medical Oncologist at IRCCS Istituto Nazionale dei Tumori, Milan
• Leads or contributes to the Head and Neck Cancer Medical Oncology Unit in Milan
• Involved in both patient care and research activities, integrating clinical trials in his practice
• Contributed to long-term institutional experience as shown by publications spanning decades

Academic Contributions

• Author of more than 160 peer-reviewed articles, many in areas of head and neck oncology, immunotherapy, and molecular oncology
• Frequent speaker at national and international oncology meetings
• Contributor to consensus statements and reviews in his field, for example on immunotherapy in recurrent/metastatic disease
• Mentorship roles and involvement in research groups and institutional projects in Milan

Areas of Expertise

• Head and neck cancer (squamous cell carcinoma, oropharynx, larynx etc.)
• Recurrent/metastatic disease and immunotherapy
• Biomarker-based patient selection and therapy personalization
• Multidisciplinary oncology care — combining medical, surgical, and radiation therapy approaches
• Translational research bridging lab and clinic

Publications and Research

Salvatore Alfieri is widely published in oncology literature, especially in head and neck cancer and immunotherapy fields. His ResearchGate profile lists over 160 publications. (e.g. articles on immunotherapy in recurrent/metastatic head and neck cancer)
One example: “Immunotherapy for recurrent/metastatic head and neck cancer” — a review summarizing the evolving role of PD-1/PD-L1 inhibitors in that setting.
Another: “Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan” — reflecting institutional surgical and oncologic collaboration over decades.

Patient Care Philosophy

• Emphasis on personalized care: selecting therapies based not only on cancer type but patient’s molecular features and tolerance
• Clear communication: explaining risks, benefits, and alternative options in understandable terms
• Commitment to research and access to novel therapies and clinical trials
• Supportive and empathetic approach: coordinating with multidisciplinary teams to support patient well-being
• Openness to international referrals, especially for specialized clinical trials or second opinions

Professional Affiliations

• Member of ESMO (European Society for Medical Oncology), with biographical membership listing
• Affiliated with IRCCS Istituto Nazionale dei Tumori, Milan
• Active contributor to oncology networks and institutional committees in Italy

FAQs

Is Dott. Salvatore Alfieri board-certified?

Yes. He is a specialized medical oncologist practicing in Italy with affiliation to a leading cancer institute.

What types of cancers does he treat?

He primarily treats head and neck cancers, recurrent/metastatic disease, and applies immunotherapy and biomarker-based treatments.

Does he accept international patients?

Yes, through the IRCCS Istituto Nazionale dei Tumori in Milan, patients from abroad may access consultation and trial enrollment.

How long is a typical hospital stay?

It depends on treatment type. Many medical oncology interventions may be outpatient. Hospitalization is for more intensive regimens or complications.

What languages does he speak?

He speaks Italian and English (as common in international research settings).

How can I schedule a consultation?

You can contact the IRCCS Istituto Nazionale dei Tumori in Milan and ask for referrals to Dott. Alfieri’s office or research unit.